$BPTH skyrockets on Received Third U.S. Patent Grant
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Provides Expanded Protection to Seminal Patents Related to DNAbilize
The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.
finance.yahoo.com/news/bio-path-receives-third-u-120000403.html
Provides Expanded Protection to Seminal Patents Related to DNAbilize
The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.
finance.yahoo.com/news/bio-path-receives-third-u-120000403.html
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。